IncellDx logo — company profile

IncellDx

Founded 2009 United States San Carlos, United States 23 employees Series Unknown Total: $9.50M Biotechnology, Health Care

General Information

Company Name IncellDx
Founded Year 2009
Location United States San Carlos, United States +1
Employees 23
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when IncellDx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About IncellDx

IncellDx is a molecular diagnostics company founded in 2009 and headquartered in the United States. The company's mission is to revolutionize healthcare by focusing on critical life-threatening diseases such as COVID-19, HIV/AIDS, lung cancer, breast cancer, bladder cancer, HPV/cervical cancer, head and neck cancer, ovarian cancer, hepatitis, and organ transplant infections. IncellDx combines molecular diagnostics with high throughput cellular analysis to provide specific molecular details about each individual cell. Their proprietary diagnostic method has the capability of revolutionizing the field of molecular diagnostics, one cell at a time. In May 2012, IncellDx received a $6.00M Venture Round investment. The investors involved in this round are not specified. The company's innovative approach to molecular diagnostics and its focus on critical diseases make it an intriguing investment opportunity in the biotechnology industry.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $500.00K - 23 Jul 2024
Venture Round $6.00M - 14 May 2012
Venture Round $3.00M - 17 Jun 2010

IncellDx Alternatives & Competitors

IncellDx vs

Solutions, Instrumentation and Assays for Cell & Molecular Biology

33 employees
IncellDx vs
Anchor Molecular
Anchor Molecular United States

Best-in-Class Quality Controls and Reference Materials for Molecular Testing

2 employees
Biotechnology, Health Care
IncellDx vs

Leading developer of NGS technologies, including in cfDNA liquid biopsies for cancer diagnostic. Par...

24 employees
Biotechnology, Health Care

FAQ About IncellDx

IncellDx is a molecular diagnostics company dedicated to revolutionizing healthcare one cell at a time. By combining molecular diagnostics with high throughput cellular analysis, we focus on critical life threatening diseases such as COVID-19, HIV/AIDs, lung cancer, breast cancer, bladder cancer, HP...
IncellDx was founded in 2009.
IncellDx is headquartered in San Carlos, United States.
IncellDx operates in the following industries: Biotechnology, Health Care.
IncellDx has approximately 23 employees.
IncellDx has completed 3 funding rounds, raising a total of $9.50M. The latest funding stage is Series Unknown.
Top alternatives and competitors to IncellDx include Biotron Healthcare (India) Pvt. Ltd, Anchor Molecular, Resolution Bioscience, Wren Laboratories, Qualisure Diagnostics Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IncellDx and Biotron Healthcare (India) Pvt. Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors IncellDx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy